Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging

ClinicalTrials.gov ID: NCT00623467

Public ClinicalTrials.gov record NCT00623467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label, Phase 3 Study to Determine the Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients Referred for Contrast-enhanced MRI of the Central Nervous System (CNS).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study involving the use of Magnetic Resonance Imaging (MRI) contrast agents called Gadavist. The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine. The results of the MRI will be compared to the results of images taken without Gadavist.

Study identification

NCT ID
NCT00623467
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
343 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2007 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Feb 10, 2014

2007 – 2008

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
HOPE Research Institute, LLC Phoenix Arizona 85050 —
Scottsdale Medical Imaging, Ltd. Scottsdale Arizona 85258 —
Radiology Ltd. Tucson Arizona 85711 —
Landmark Imaging Medical Group Los Angeles California 90025 —
Cedars- Sinai Medical Center Los Angeles California 90048 —
Sharp & Children's MRI Center San Diego California 92123 —
University of Florida - Jacksonville Jacksonville Florida 32209 —
University of South Florida Tampa Florida 33606 —
River Birch Research Alliance, LLC Blue Ridge Georgia 30513 —
Eisenhower Army Medical Center Fort Gordon Georgia 30905 —
University of Michigan Health System Ann Arbor Michigan 48109-5302 —
Henry Ford Health System Detroit Michigan 48202 —
Bio-Magnetic Resonance, Inc. Madison Heights Michigan 48071 —
Maimonides Medical Center Brooklyn New York 11219 —
Mount Sinai Medical Center New York New York 10029 —
University of Rochester Medical Center Rochester New York 14642 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157 —
Hahnemann University Hospital Philadelphia Pennsylvania 19102 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Medical University of South Carolina Charleston South Carolina 29425 —
Baylor College of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00623467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00623467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →